IPG Investment Advisors’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,166
| Closed | -$12.5K | – | 229 |
|
|
2023
Q4 | $12.5K | Buy |
+1,166
| New | +$12.5K | ﹤0.01% | 192 |
|
|
2023
Q3 | – | Sell |
-1,185
| Closed | -$8.17K | – | 191 |
|
|
2023
Q2 | $8.17K | Hold |
1,185
| – | – | ﹤0.01% | 170 |
|
|
2023
Q1 | $18.6K | Hold |
1,185
| – | – | ﹤0.01% | 161 |
|
|
2022
Q4 | $23.7K | Hold |
1,185
| – | – | 0.01% | 133 |
|
|
2022
Q3 | $21.1K | Hold |
1,185
| – | – | 0.01% | 133 |
|
|
2022
Q2 | $26K | Hold |
1,185
| – | – | 0.01% | 149 |
|
|
2022
Q1 | $33K | Hold |
1,185
| – | – | 0.01% | 164 |
|
|
2021
Q4 | $54K | Sell |
1,185
-353
| -23% | -$16.1K | 0.01% | 199 |
|
|
2021
Q3 | $128K | Sell |
1,538
-17
| -1% | -$1.42K | 0.04% | 121 |
|
|
2021
Q2 | $148K | Hold |
1,555
| – | – | 0.04% | 133 |
|
|
2021
Q1 | $259K | Buy |
+1,555
| New | +$259K | 0.05% | 158 |
|